These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26883200)

  • 41. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
    Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer.
    Qiu J; Yang B
    Mol Cell Biochem; 2021 Jan; 476(1):1-10. PubMed ID: 32935296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Srebp-1 Interacts with c-Myc to Enhance Somatic Cell Reprogramming.
    Wu Y; Chen K; Liu X; Huang L; Zhao D; Li L; Gao M; Pei D; Wang C; Liu X
    Stem Cells; 2016 Jan; 34(1):83-92. PubMed ID: 26388522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway.
    Kanagasabai T; Li G; Shen TH; Gladoun N; Castillo-Martin M; Celada SI; Xie Y; Brown LK; Mark ZA; Ochieng J; Ballard BR; Cordon-Cardo C; Adunyah SE; Jin R; Matusik RJ; Chen Z
    Cancer Lett; 2022 Jan; 525():46-54. PubMed ID: 34610416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
    Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
    Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SOX4 is activated by C-MYC in prostate cancer.
    Dong H; Hu J; Wang L; Qi M; Lu N; Tan X; Yang M; Bai X; Zhan X; Han B
    Med Oncol; 2019 Sep; 36(11):92. PubMed ID: 31560094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
    Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
    Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
    Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM
    Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulforaphane Inhibits c-Myc-Mediated Prostate Cancer Stem-Like Traits.
    Vyas AR; Moura MB; Hahm ER; Singh KB; Singh SV
    J Cell Biochem; 2016 Nov; 117(11):2482-95. PubMed ID: 26990292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
    Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
    Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
    Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
    Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extrachromosomal circular DNA promotes prostate cancer progression through the FAM84B/CDKN1B/MYC/WWP1 axis.
    Jin W; Xu Z; Song Y; Chen F
    Cell Mol Biol Lett; 2024 Jul; 29(1):103. PubMed ID: 38997648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.
    Takizawa I; Lawrence MG; Balanathan P; Rebello R; Pearson HB; Garg E; Pedersen J; Pouliot N; Nadon R; Watt MJ; Taylor RA; Humbert P; Topisirovic I; Larsson O; Risbridger GP; Furic L
    Oncotarget; 2015 Jan; 6(2):604-16. PubMed ID: 25436982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-κB Regulation.
    Guo Z; Xing Z; Cheng X; Fang Z; Jiang C; Su J; Zhou Z; Xu Z; Holmberg A; Nilsson S; Liu Z
    PLoS One; 2015; 10(5):e0124292. PubMed ID: 26010447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.
    Karanika S; Karantanos T; Kurosaka S; Wang J; Hirayama T; Yang G; Park S; Golstov AA; Tanimoto R; Li L; Thompson TC
    Mol Cancer; 2015 Jun; 14():122. PubMed ID: 26084402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
    Su W; Han HH; Wang Y; Zhang B; Zhou B; Cheng Y; Rumandla A; Gurrapu S; Chakraborty G; Su J; Yang G; Liang X; Wang G; Rosen N; Scher HI; Ouerfelli O; Giancotti FG
    Cancer Cell; 2019 Aug; 36(2):139-155.e10. PubMed ID: 31327655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rap2B promotes cell proliferation, migration and invasion in prostate cancer.
    Di J; Cao H; Tang J; Lu Z; Gao K; Zhu Z; Zheng J
    Med Oncol; 2016 Jun; 33(6):58. PubMed ID: 27154636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.